Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions
The aim is to analyze the medical records of patients with malignant lymphoproliferative diseases (LPD) in the Russian Federation in 2016- 2017. Materials and methods. Treating physicians in 75 regions of the Russian Federation were asked to fill the survey questionnaire containing 9 types of malign...
Saved in:
| Main Authors: | G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2019-01-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidemiology, Survival, and Second Primary Malignancies in T‐Cell Large Granular Lymphocytic Leukemia
by: Arya Mariam Roy, et al.
Published: (2025-06-01) -
T Cell Repertoire Analysis as a Molecular Signature of the Spectrum of T-LGL Lymphoproliferative Disorders: Tracing the Literature
by: Evangelia Stalika, et al.
Published: (2025-04-01) -
Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review
by: Jessie Luo, et al.
Published: (2024-11-01) -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS
by: Pietro Tralongo, et al.
Published: (2024-04-01) -
Prevalence of medical writing in hematological malignancy review articles
by: Héctor A. Vaquera-Alfaro, et al.
Published: (2025-04-01)